Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Assets: 2009-2025

Historic Assets for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to $538.2 million.

  • Cross Country Healthcare's Assets fell 990.79% to $538.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 1076.26%. This contributed to the annual value of $589.3 million for FY2024, which is 1348.08% down from last year.
  • As of Q3 2025, Cross Country Healthcare's Assets stood at $538.2 million, which was down 990.79% from $553.8 million recorded in Q2 2025.
  • Cross Country Healthcare's 5-year Assets high stood at $949.6 million for Q4 2022, and its period low was $442.4 million during Q1 2021.
  • Over the past 5 years, Cross Country Healthcare's median Assets value was $648.4 million (recorded in 2024), while the average stood at $687.6 million.
  • In the last 5 years, Cross Country Healthcare's Assets soared by 10717.26% in 2022 and then tumbled by 2955.89% in 2024.
  • Over the past 5 years, Cross Country Healthcare's Assets (Quarter) stood at $732.8 million in 2021, then grew by 29.58% to $949.6 million in 2022, then fell by 28.28% to $681.1 million in 2023, then fell by 13.48% to $589.3 million in 2024, then fell by 8.66% to $538.2 million in 2025.
  • Its Assets stands at $538.2 million for Q3 2025, versus $553.8 million for Q2 2025 and $576.2 million for Q1 2025.